4//SEC Filing
Jacobs John C 4
Accession 0001209191-23-004855
CIK 0001000694other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 5:06 PM ET
Size
8.3 KB
Accession
0001209191-23-004855
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
Jacobs John C
DirectorPresident and CEO
Transactions
- Award
Restricted Stock Units
2023-01-23+249,590→ 249,590 total→ Common Stock (249,590 underlying) - Award
Stock Option (Right to buy)
2023-01-23+290,700→ 290,700 totalExercise: $11.92From: 2024-01-23Exp: 2033-01-23→ Common Stock (290,700 underlying)
Footnotes (3)
- [F1]Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") 2023 Inducement Plan (the "Plan") will vest on the first anniversary of the January 23, 2023 grant date (the "Grant Date"), and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment through such vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.
- [F3]The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date.
Documents
Issuer
NOVAVAX INC
CIK 0001000694
Entity typeother
Related Parties
1- filerCIK 0001820836
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 5:06 PM ET
- Size
- 8.3 KB